TCRT logo

Alaunos Therapeutics, Inc. Common Stock


TCRT: Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.


Show TCRT Financials

Consumer Interest
SEC Filings

Recent trades of TCRT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by TCRT's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of TCRT in WallStreetBets Daily Discussion


Recent insights relating to TCRT

CNBC Recommendations

Recent picks made for TCRT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TCRT

Corporate Flights

Flights by private jets registered to TCRT